Related Experiment Videos
B-lymphoproliferative disorders in patients with hepatitis C virus infection
Insights
Hepatitis C virus infection is linked to a higher prevalence of B lymphoproliferative disorders, particularly those with mixed cryoglobulinemia. Further research is needed to confirm this association and guide screening strategies.
Area of Science:
- Rheumatology
- Hepatology
- Oncology
Background:
- Investigated the association between Hepatitis C virus (HCV) infection and B lymphoproliferative disorders.
- Studied a cohort of 148 patients with confirmed HCV infection at a tertiary care rheumatology clinic.
- Assessed cryoglobulinemia prevalence and types in HCV patients.
Discussion:
- Observed a 2.7% prevalence of B lymphoproliferative disorders in the HCV cohort.
- Found that all four patients with B lymphoproliferative disorders had mixed cryoglobulinemia (MC).
- Highlighted that two patients had type II MC and two had type III MC.
Key Insights:
- The incidence of B lymphoproliferative disorders appears significantly increased in HCV-infected patients.
- Mixed cryoglobulinemia, especially type II and III, is frequently present in HCV patients who develop B lymphoproliferative disorders.
- The high prevalence of undiagnosed HCV in the general population may impact the observed association's significance.
Outlook:
- Recommends systematic cryoglobulin screening in HCV patients to clarify the risk associated with type II and III MC.
- Suggests further investigation into the pathogenic mechanisms linking HCV, cryoglobulinemia, and lymphoproliferative disorders.
- Emphasizes the need for larger studies to confirm the increased risk and inform clinical practice.
Abstract:
A cohort of 148 consecutive patients with hepatitis C virus infection were studied at the rheumatology out-patient clinic of a tertiary care teaching hospital. The diagnosis of hepatitis C virus infection was supported by detection of HCV RNA in the serum. Cryoglobulin screening was done in all patients and the presence of a monoclonal component was investigated when the cryocrit was higher than 1%. Patients with lymphoproliferative disorders were further investigated. Four patients had a B lymphoproliferative disorder, which represents a prevalence of 2.7% in this cohort of patients with hepatitis C virus infection. Mixed cryoglobulinemia (MC), with cryocrit higher than 1%, was found in 16 of 148 patients (11%). It was type III MC in 13 patients and type II MC in 3. All patients who developed a B lymphoproliferative disorder had mixed cryoglobulinemia, with a monoclonal component (type II MC) in two patients and without a monoclonal component (type III MC) in the other two. The incidence of B-lymphoproliferative disorders among this cohort of patients with hepatitis C virus infection seems to be significantly increased. However, the high frequency of asymptomatic, undiagnosed HCV infection among the apparently healthy general population may decrease the true significance of this association. Systematic screening of cryoglobulin production in patients with hepatitis C virus infection might clarify whether the risk of B lymphoproliferative disorders increases when type II or type III mixed cryoglobulinemia is present.